Gil HardyDirectorIpanema Research TrustProfessor Gil Hardy, PhD, FRSC, FASPEN Gil Hardy is Emeritus Professor of Clinical Nutrition in Auckland New Zealand. He trained as a biochemist in the UK where he carried out research in the Metabolic Research Laboratory of Nobel Prize Winner, Professor Sir Hans Krebs at the University of Oxford. Working with colleagues at St Marks Hospital, London he developed the first 3 litre Parenteral Nutrition bag for patients with intestinal failure. Professor Hardy has over 250 publications from his extensive research with lipids, glutamine, micronutrients and most recently chyme reinfusion therapy. Gil is a founder and life member of the British Pharmaceutical Nutrition Group and has served on Councils of BAPEN, the UK and New Zealand Nutrition Societies and as vice president of AuSPEN. He has been associated with ESPEN and ASPEN since their formation, most recently on the Research, Membership and FASPEN committees of ASPEN and remains a faculty member of ESPEN. He has an international reputation in the field of pharmaceutical and clinical nutrition with awards and honorary fellowships from Asia, Australasia, Europe, Latin America and USA, including the Distinguished International Nutrition Support Specialist Award from ASPEN in 2014. Gil was the founder and first chairman of the international clinical nutrition section (ICNS) and in 2020 he was appointed to the ASPEN Board of Directors. He represents ASPEN on the International Human Rights for Clinical Nutrition working group and was recently appointed to the board of the West African Society of Parenteral and Enteral Nutrition (WASPEN).Chyme Reinfusion Therapy Parenteral and Enteral Nutrition Micronutrients for the critically ill Human Rights in Clinical NutritionSMART Award for Innovation (UK Department of Health) 1996. ASPEN Distinguished International Nutrition Support Specialist Award 2014 Lifetime Achievement Award. Parenteral Nutrition Down Under (Australasian HPN patient support group) 2017 Appointed to the ASPEN Board of Directors 2020-2022. New Zealand

Gil HardyDirectorIpanema Research TrustProfessor Gil Hardy, PhD, FRSC, FASPEN
Gil Hardy is Emeritus Professor of Clinical Nutrition in Auckland
New Zealand. He trained as a biochemist in the UK where he
carried out research in the Metabolic Research Laboratory of
Nobel Prize Winner, Professor Sir Hans Krebs at the University
of Oxford. Working with colleagues at St Marks Hospital,
London he developed the first 3 litre Parenteral Nutrition bag for
patients with intestinal failure. Professor Hardy has over 250
publications from his extensive research with lipids, glutamine,
micronutrients and most recently chyme reinfusion therapy.
Gil is a founder and life member of the British Pharmaceutical
Nutrition Group and has served on Councils of BAPEN, the UK
and New Zealand Nutrition Societies and as vice president of
AuSPEN. He has been associated with ESPEN and ASPEN
since their formation, most recently on the Research,
Membership and FASPEN committees of ASPEN and remains
a faculty member of ESPEN. He has an international reputation
in the field of pharmaceutical and clinical nutrition with awards
and honorary fellowships from Asia, Australasia, Europe, Latin
America and USA, including the Distinguished International
Nutrition Support Specialist Award from ASPEN in 2014. Gil
was the founder and first chairman of the international clinical
nutrition section (ICNS) and in 2020 he was appointed to the
ASPEN Board of Directors. He represents ASPEN on the
International Human Rights for Clinical Nutrition working group
and was recently appointed to the board of the West African
Society of Parenteral and Enteral Nutrition (WASPEN).Chyme Reinfusion Therapy
Parenteral and Enteral Nutrition
Micronutrients for the critically ill
Human Rights in Clinical NutritionSMART Award for Innovation (UK Department of Health) 1996.
ASPEN Distinguished International Nutrition Support Specialist Award 2014 Lifetime Achievement Award. Parenteral Nutrition Down Under (Australasian HPN patient support group) 2017
Appointed to the ASPEN Board of Directors 2020-2022.
New Zealand

Day 2 | 9th Nov 2024

Time Session
09:00
10:30
Mohammad Shukri Jahit Chairperson Malaysia
Sanjith Saseedharan Chairperson India
  • Developing Home PN Programme - The European Experience
    Stanislaw Klek Speaker Poland
  • Nutritional Management of Intestinal Failure With Chyme Reinfusion Therapy
    Gil Hardy Speaker New Zealand
  • Role of GLP-2 in Short Bowel Syndrome
    Doris Ng Hui Lan Speaker Singapore
  • Requirements for Micronutrients Among Home PN Patients
    Maria Christina Kristin S. Reyes Speaker Philippines
  • Q&A Session
Sabah Room